A novel occludin-targeting monoclonal antibody prevents hepatitis C virus infection in vitro
A novel occludin-targeting monoclonal antibody prevents hepatitis C virus infection in vitro |
|
https://doi.org/10.18632/oncotarget.24742
Ken Okai,
Naoki Ichikawa-Tomikawa,
Akira C. Saito,
Tetsuya Watabe,
Kotaro Sugimoto,
Daiki Fujita,
Chikako Ono,
Takasuke Fukuhara,
Yoshiharu Matsuura,
Hiromasa Ohira,
and Hideki Chiba
|
| 16588-16598 |
Momelotinib decreased cancer stem cell associated tumor burden and prolonged disease-free remission period in a mouse model of human ovarian cancer
Momelotinib decreased cancer stem cell associated tumor burden and prolonged disease-free remission period in a mouse model of human ovarian cancer |
|
https://doi.org/10.18632/oncotarget.24615
Emily Chan,
Rodney Luwor,
Christopher Burns,
George Kannourakis,
Jock K. Findlay,
and Nuzhat Ahmed
|
| 16599-16618 |
Improved therapy for medulloblastoma: targeting hedgehog and PI3K-mTOR signaling pathways in combination with chemotherapy
Improved therapy for medulloblastoma: targeting hedgehog and PI3K-mTOR signaling pathways in combination with chemotherapy |
|
https://doi.org/10.18632/oncotarget.24618
Nagendra K. Chaturvedi,
Matthew J. Kling,
Don W. Coulter,
Timothy R. McGuire,
Sutapa Ray,
Varun Kesherwani,
Shantaram S. Joshi,
and J. Graham Sharp
|
| 16619-16633 |
Esophageal squamous cell carcinoma transcriptome reveals the effect of FOXM1 on patient outcome through novel PIK3R3 mediated activation of PI3K signaling pathway
Esophageal squamous cell carcinoma transcriptome reveals the effect of FOXM1 on patient outcome through novel PIK3R3 mediated activation of PI3K signaling pathway |
|
https://doi.org/10.18632/oncotarget.24621
Pedro Nicolau-Neto,
Nathalia Meireles Da Costa,
Paulo Thiago de Souza Santos,
Isabela Martins Gonzaga,
Maria Aparecida Ferreira,
Simone Guaraldi,
Miguel Angelo Moreira,
Hector N. Seuánez,
Lilian Brewer,
Anke Bergmann,
Mariana Boroni,
Andre Luiz Mencalha,
Cleber Dario Pinto Kruel,
Sheila Coelho Soares Lima,
Dominic Esposito,
Tatiana Almeida Simão4,
and Luis Felipe Ribeiro Pinto
|
| 16634-16647 |
ALCAM shedding at the invasive front of the tumor is a marker of myometrial infiltration and promotes invasion in endometrioid endometrial cancer
ALCAM shedding at the invasive front of the tumor is a marker of myometrial infiltration and promotes invasion in endometrioid endometrial cancer |
|
https://doi.org/10.18632/oncotarget.24625
Laura Devis,
Elena Martinez-Garcia,
Cristian P. Moiola,
Maria Teresa Quiles,
Maria Antonia Arbos,
Tomita Vasilica Stirbat,
Françoise Brochard-Wyart,
Ángel García,
Lorena Alonso-Alconada,
Miguel Abal,
Berta Diaz-Feijoo,
William Thomas,
Sylvie Dufour,
Gemma Mancebo,
Francesc Alameda,
Jaume Reventos,
Antonio Gil-Moreno,
and Eva Colas
|
| 16648-16664 |
High CTLA-4 expression correlates with poor prognosis in thymoma patients
High CTLA-4 expression correlates with poor prognosis in thymoma patients |
|
https://doi.org/10.18632/oncotarget.24645
Giorgio Santoni,
Consuelo Amantini,
Maria Beatrice Morelli,
Daniele Tomassoni,
Matteo Santoni,
Oliviero Marinelli,
Massimo Nabissi,
Claudio Cardinali,
Vittorio Paolucci,
Mariangela Torniai,
Silvia Rinaldi,
Francesca Morgese,
Giovanni Bernardini,
and Rossana Berardi
|
| 16665-16677 |
Chemerin induces endothelial cell inflammation: activation of nuclear factor-kappa beta and monocyte-endothelial adhesion
Chemerin induces endothelial cell inflammation: activation of nuclear factor-kappa beta and monocyte-endothelial adhesion |
|
https://doi.org/10.18632/oncotarget.24659
Georgios K. Dimitriadis,
Jaspreet Kaur,
Raghu Adya,
Alexander D. Miras,
Harman S. Mattu,
John G. Hattersley,
Gregory Kaltsas,
Bee K. Tan,
and Harpal S. Randeva
|
| 16678-16690 |
Prognostic value of circulating microRNAs in upper tract urinary carcinoma
Prognostic value of circulating microRNAs in upper tract urinary carcinoma |
|
https://doi.org/10.18632/oncotarget.24672
Ruth Montalbo,
Laura Izquierdo,
Mercedes Ingelmo-Torres,
Juan José Lozano,
David Capitán,
Antonio Alcaraz,
and Lourdes Mengual
|
| 16691-16700 |
Antiapoptotic BCL-2 proteins determine sorafenib/regorafenib resistance and BH3-mimetic efficacy in hepatocellular carcinoma
Antiapoptotic BCL-2 proteins determine sorafenib/regorafenib resistance and BH3-mimetic efficacy in hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.24673
Anna Tutusaus,
Milica Stefanovic,
Loreto Boix,
Blanca Cucarull,
Aynara Zamora,
Laura Blasco,
Pablo García de Frutos,
Maria Reig,
Jose C. Fernandez-Checa,
Montserrat Marí,
Anna Colell,
Jordi Bruix,
and Albert Morales
|
| 16701-16717 |
Glycogen debranching enzyme (AGL) is a novel regulator of non-small cell lung cancer growth
Glycogen debranching enzyme (AGL) is a novel regulator of non-small cell lung cancer growth |
|
https://doi.org/10.18632/oncotarget.24676
Craig S. Richmond,
Darby Oldenburg,
Garrett Dancik,
David R. Meier,
Benjamin Weinhaus,
Dan Theodorescu,
and Sunny Guin
|
| 16718-16730 |
High competing risks minimize real-world utility of adjuvant targeted therapy in renal cell carcinoma: a population-based analysis
High competing risks minimize real-world utility of adjuvant targeted therapy in renal cell carcinoma: a population-based analysis |
|
https://doi.org/10.18632/oncotarget.24675
Thenappan Chandrasekar,
Zachary Klaassen,
Hanan Goldberg,
Rashid K. Sayyid,
and Neil E. Fleshner
|
| 16731-16743 |
Anti-cancerous effect of cis-khellactone from Angelica amurensis through the induction of three programmed cell deaths
Anti-cancerous effect of cis-khellactone from Angelica amurensis through the induction of three programmed cell deaths |
|
https://doi.org/10.18632/oncotarget.24686
Samil Jung,
Hyung-In Moon,
Beom Suk Lee,
Subeen Kim,
Nguyen Thi Ngoc Quynh,
Jimin Yu,
Dan-Diem Thi Le,
Zolzaya Sandag,
Hyegyeong Lee,
Hyojeong Lee,
Nguyen Hai Anh,
Young Yang,
Jong-Seok Lim,
Keun-Il Kim,
and Myeong-Sok Lee
|
| 16744-16757 |
Application of a double-colour upconversion nanofluorescent probe for targeted imaging of mantle cell lymphoma
Application of a double-colour upconversion nanofluorescent probe for targeted imaging of mantle cell lymphoma |
|
https://doi.org/10.18632/oncotarget.23860
Guang Yang,
Yong Cao,
Bin Yan,
Qiang Lv,
Jianbo Yu,
Fusheng Zhao,
Zhihong Chen,
Heran Yang,
Mengxi Chen,
and Zaishun Jin
|
| 16758-16774 |
Canonical NF-κB signaling in myeloid cells promotes lung metastasis in a mouse breast cancer model
Canonical NF-κB signaling in myeloid cells promotes lung metastasis in a mouse breast cancer model |
|
https://doi.org/10.18632/oncotarget.24697
Tobias Neumann,
Özge Canli,
and Florian R. Greten
|
| 16775-16791 |
STAT5 inhibition induces TRAIL/DR4 dependent apoptosis in peripheral T-cell lymphoma
STAT5 inhibition induces TRAIL/DR4 dependent apoptosis in peripheral T-cell lymphoma |
|
https://doi.org/10.18632/oncotarget.24698
Haley M. Simpson,
Aki Furusawa,
Kavitha Sadashivaiah,
Curt I. Civin,
and Arnob Banerjee
|
| 16792-16806 |
Novel drug-resistance mechanisms of pemetrexed-treated non-small cell lung cancer
Novel drug-resistance mechanisms of pemetrexed-treated non-small cell lung cancer |
|
https://doi.org/10.18632/oncotarget.24704
Ryosuke Tanino,
Yukari Tsubata,
Nanae Harashima,
Mamoru Harada,
and Takeshi Isobe
|
| 16807-16821 |
Prognostic value of early 18F-FDG PET scanning evaluation in immunocompetent primary CNS lymphoma patients
Prognostic value of early 18F-FDG PET scanning evaluation in immunocompetent primary CNS lymphoma patients |
|
https://doi.org/10.18632/oncotarget.24706
Rudy Birsen,
Estelle Blanc,
Lise Willems,
Barbara Burroni,
Marielle Legoff,
Emmanuelle Le Ray,
Sylvain Pilorge,
Sawsen Salah,
Aude Quentin,
Benedicte Deau,
Patricia Franchi,
Marguerite Vignon,
Laurence Mabille,
Charles Nguyen,
Yioula Kirova,
Pascale Varlet,
Myriam Edjlali,
Edouard Dezamis,
Khê Hoang-Xuan,
Carole Soussain,
Caroline Houillier,
Diane Damotte,
Johan Pallud,
Didier Bouscary,
and Jerome Tamburini
|
| 16822-16831 |
Imaging markers of response to combined BRAF and MEK inhibition in BRAF mutated vemurafenib-sensitive and resistant melanomas
Imaging markers of response to combined BRAF and MEK inhibition in BRAF mutated vemurafenib-sensitive and resistant melanomas |
|
https://doi.org/10.18632/oncotarget.24709
Stefania Acciardo,
Lionel Mignion,
Nicolas Joudiou,
Caroline Bouzin,
Jean-François Baurain,
Bernard Gallez,
and Bénédicte F. Jordan
|
| 16832-16846 |
Cisplatin liposome and 6-amino nicotinamide combination to overcome drug resistance in ovarian cancer cells
Cisplatin liposome and 6-amino nicotinamide combination to overcome drug resistance in ovarian cancer cells |
|
https://doi.org/10.18632/oncotarget.24708
Daniela Catanzaro,
Silvia Nicolosi,
Veronica Cocetta,
Marika Salvalaio,
Andrea Pagetta,
Eugenio Ragazzi,
Monica Montopoli,
and Gianfranco Pasut
|
| 16847-16860 |
The JmjN domain as a dimerization interface and a targeted inhibitor of KDM4 demethylase activity
The JmjN domain as a dimerization interface and a targeted inhibitor of KDM4 demethylase activity |
|
https://doi.org/10.18632/oncotarget.24717
May Levin,
Michal Stark,
and Yehuda G. Assaraf
|
| 16861-16882 |
Incidence and risk factors for venous thromboembolism in patients with pretreated advanced pancreatic carcinoma
Incidence and risk factors for venous thromboembolism in patients with pretreated advanced pancreatic carcinoma |
|
https://doi.org/10.18632/oncotarget.24721
Shunsuke Kondo,
Mitsuhito Sasaki,
Hiroko Hosoi,
Yasunari Sakamoto,
Chigusa Morizane,
Hideki Ueno,
and Takuji Okusaka
|
| 16883-16890 |
ATM/RB1 mutations predict shorter overall survival in urothelial cancer
ATM/RB1 mutations predict shorter overall survival in urothelial cancer |
|
https://doi.org/10.18632/oncotarget.24738
Ming Yin,
Petros Grivas,
Hamid Emamekhoo,
Prateek Mendiratta,
Siraj Ali,
JoAnn Hsu,
Monali Vasekar,
Joseph J. Drabick,
Sumanta Pal,
and Monika Joshi
|
| 16891-16898 |
Competitive docking model for prediction of the human nicotinic acetylcholine receptor α7 binding of tobacco constituents
Competitive docking model for prediction of the human nicotinic acetylcholine receptor α7 binding of tobacco constituents |
|
https://doi.org/10.18632/oncotarget.24458
Hui Wen Ng,
Carmine Leggett,
Sugunadevi Sakkiah,
Bohu Pan,
Hao Ye,
Leihong Wu,
Chandrabose Selvaraj,
Weida Tong,
and Huixiao Hong
|
| 16899-16916 |
A novel, dual pan-PIM/FLT3 inhibitor SEL24 exhibits broad therapeutic potential in acute myeloid leukemia
A novel, dual pan-PIM/FLT3 inhibitor SEL24 exhibits broad therapeutic potential in acute myeloid leukemia |
|
https://doi.org/10.18632/oncotarget.24747
Wojciech Czardybon,
Renata Windak,
Aniela Gołas,
Michał Gałęzowski,
Aleksandra Sabiniarz,
Izabela Dolata,
Magdalena Salwińska,
Paweł Guzik,
Magdalena Zawadzka,
Ewelina Gabor-Worwa,
Bożena Winnik,
Małgorzata Żurawska,
Ewa Kolasińska,
Ewelina Wincza,
Marta Bugaj,
Monika Danielewicz,
Eliza Majewska,
Milena Mazan,
Grzegorz Dubin,
Monika Noyszewska-Kania,
Ewa Jabłońska,
Maciej Szydłowski,
Tomasz Sewastianik,
Bartosz Puła,
Anna Szumera-Ciećkiewicz,
Monika Prochorec-Sobieszek,
Elżbieta Mądro,
Ewa Lech-Marańda,
Krzysztof Warzocha,
Jerome Tamburini,
Przemysław Juszczyński,
and Krzysztof Brzózka
|
| 16917-16931 |
Results and adverse events of personalized peptide receptor radionuclide therapy with 90Yttrium and 177Lutetium in 1048 patients with neuroendocrine neoplasms
Results and adverse events of personalized peptide receptor radionuclide therapy with 90Yttrium and 177Lutetium in 1048 patients with neuroendocrine neoplasms |
|
https://doi.org/10.18632/oncotarget.24524
Richard P. Baum,
Harshad R. Kulkarni,
Aviral Singh,
Daniel Kaemmerer,
Dirk Mueller,
Vikas Prasad,
Merten Hommann,
Franz C. Robiller,
Karin Niepsch,
Holger Franz,
Arthur Jochems,
Philippe Lambin,
and Dieter Hörsch
|
| 16932-16950 |
Testosterone metabolites inhibit proliferation of castration- and therapy-resistant prostate cancer
Testosterone metabolites inhibit proliferation of castration- and therapy-resistant prostate cancer |
|
https://doi.org/10.18632/oncotarget.24763
Felix Bremmer,
Hubertus Jarry,
Valerie Unterkircher,
Silke Kaulfuss,
Peter Burfeind,
Heinz-Joachim Radzun,
Philipp Ströbel,
and Paul Thelen
|
| 16951-16961 |
Synthesis and anticancer activity of the derivatives of marine compound rhizochalin in castration resistant prostate cancer
Synthesis and anticancer activity of the derivatives of marine compound rhizochalin in castration resistant prostate cancer |
|
https://doi.org/10.18632/oncotarget.24764
Sergey A. Dyshlovoy,
Katharina Otte,
Kseniya M. Tabakmakher,
Jessica Hauschild,
Tatyana N. Makarieva,
Larisa K. Shubina,
Sergey N. Fedorov,
Carsten Bokemeyer,
Valentin A. Stonik,
and Gunhild von Amsberg
|
| 16962-16973 |
Blood free-circulating DNA testing by highly sensitive methylation assay to diagnose colorectal neoplasias
Blood free-circulating DNA testing by highly sensitive methylation assay to diagnose colorectal neoplasias |
|
https://doi.org/10.18632/oncotarget.24768
Yutaka Suehiro,
Shinichi Hashimoto,
Shingo Higaki,
Ikuei Fujii,
Chieko Suzuki,
Tomomi Hoshida,
Toshihiko Matsumoto,
Yuko Yamaoka,
Taro Takami,
Isao Sakaida,
and Takahiro Yamasaki
|
| 16974-16987 |
Non-secretion of AFP and neutrophil lymphocyte ratio as predictors for survival in hepatocellular carcinoma patients treated with sorafenib: a large UK cohort
Non-secretion of AFP and neutrophil lymphocyte ratio as predictors for survival in hepatocellular carcinoma patients treated with sorafenib: a large UK cohort |
|
https://doi.org/10.18632/oncotarget.24769
Mehran Afshar,
Peter Fletcher,
Antonio D. Bardoli,
Yuk Ting Ma,
and Pankaj Punia
|
| 16988-16995 |
Small molecule CXCR4 antagonists block the HIV-1 Nef/CXCR4 axis and selectively initiate the apoptotic program in breast cancer cells
Small molecule CXCR4 antagonists block the HIV-1 Nef/CXCR4 axis and selectively initiate the apoptotic program in breast cancer cells |
|
https://doi.org/10.18632/oncotarget.24580
Ming-Bo Huang,
Kyle E. Giesler,
Brooke M. Katzman,
Anthony R. Prosser,
Valarie Truax,
Dennis C. Liotta,
Lawrence J. Wilson,
and Vincent C. Bond
|
| 16996-17013 |
Molecular signatures associated with tumor-specific immune response in melanoma patients treated with dendritic cell-based immunotherapy
Molecular signatures associated with tumor-specific immune response in melanoma patients treated with dendritic cell-based immunotherapy |
|
https://doi.org/10.18632/oncotarget.24795
Tamara García-Salum,
Andrea Villablanca,
Franziska Matthäus,
Andrés Tittarelli,
Mauricio Baeza,
Cristián Pereda,
M. Alejandra Gleisner,
Fermín E. González,
Mercedes N. López,
Jörg D. Hoheisel,
Johannes Norgauer,
Peter J. Gebicke-Haerter,
and Flavio Salazar-Onfray
|
| 17014-17027 |
CTCF-KDM4A complex correlates with histone modifications that negatively regulate CHD5 gene expression in cancer cell lines
CTCF-KDM4A complex correlates with histone modifications that negatively regulate CHD5 gene expression in cancer cell lines |
|
https://doi.org/10.18632/oncotarget.24798
Lissania Guerra-Calderas,
Rodrigo González-Barrios,
Carlos César Patiño,
Nicolás Alcaraz,
Marisol Salgado-Albarrán,
David Cantú de León,
Clementina Castro Hernández,
Yesennia Sánchez-Pérez,
Héctor Aquiles Maldonado-Martínez,
Inti A. De la Rosa-Velazquez,
Fernanda Vargas-Romero,
Luis A. Herrera,
Alejandro García-Carrancá,
and Ernesto Soto-Reyes
|
| 17028-17042 |
Mutation analysis of the EGFR pathway genes, EGFR, RAS, PIK3CA, BRAF, and AKT1, in salivary gland adenoid cystic carcinoma
Mutation analysis of the EGFR pathway genes, EGFR, RAS, PIK3CA, BRAF, and AKT1, in salivary gland adenoid cystic carcinoma |
|
https://doi.org/10.18632/oncotarget.24818
Kosuke Saida,
Takayuki Murase,
Mayuko Ito,
Kana Fujii,
Hisashi Takino,
Ayako Masaki,
Daisuke Kawakita,
Kei Ijichi,
Yuichiro Tada,
Kimihide Kusafuka,
Yoshiyuki Iida,
Tetsuro Onitsuka,
Yasushi Yatabe,
Nobuhiro Hanai,
Yasuhisa Hasegawa,
Hitomi Shinomiya,
Ken-Ichi Nibu,
Kazuo Shimozato,
and Hiroshi Inagaki
|
| 17043-17055 |
CDX2 expression is concordant between primary colorectal cancer lesions and corresponding liver metastases independent of chemotherapy: a single-center retrospective study in Japan
CDX2 expression is concordant between primary colorectal cancer lesions and corresponding liver metastases independent of chemotherapy: a single-center retrospective study in Japan |
|
https://doi.org/10.18632/oncotarget.24842
Yasuyuki Shigematsu,
Kentaro Inamura,
Yoshihiro Mise,
Akio Saiura,
Emil Rehnberg,
Noriko Yamamoto,
Yuichi Ishikawa,
Shunji Takahashi,
and Hiroaki Kanda
|
| 17056-17065 |
Ferric citrate and ferric EDTA but not ferrous sulfate drive amphiregulin-mediated activation of the MAP kinase ERK in gut epithelial cancer cells
Ferric citrate and ferric EDTA but not ferrous sulfate drive amphiregulin-mediated activation of the MAP kinase ERK in gut epithelial cancer cells |
|
https://doi.org/10.18632/oncotarget.24899
Nathalie M. Scheers,
Dora I.A. Pereira,
Nuno Faria,
and Jonathan J. Powell
|
| 17066-17077 |
Copy number changes at 8p11-12 predict adverse clinical outcome and chemo- and radiotherapy response in breast cancer
Copy number changes at 8p11-12 predict adverse clinical outcome and chemo- and radiotherapy response in breast cancer |
|
https://doi.org/10.18632/oncotarget.24904
Cathy B. Moelans,
Caroline M.G. van Maldegem,
Elsken van der Wall,
and Paul J. van Diest
|
| 17078-17092 |
Racial differences in endometrial cancer molecular portraits in The Cancer Genome Atlas
Racial differences in endometrial cancer molecular portraits in The Cancer Genome Atlas |
|
https://doi.org/10.18632/oncotarget.24907
David S. Guttery,
Kevin Blighe,
Konstantinos Polymeros,
R. Paul Symonds,
Salvador Macip,
and Esther L. Moss
|
| 17093-17103 |
Development of a quantitative pharmacodynamic assay for apoptosis in fixed tumor tissue and its application in distinguishing cytotoxic drug−induced DNA double strand breaks from DNA double strand breaks associated with apoptosis
Development of a quantitative pharmacodynamic assay for apoptosis in fixed tumor tissue and its application in distinguishing cytotoxic drug−induced DNA double strand breaks from DNA double strand breaks associated with apoptosis |
|
https://doi.org/10.18632/oncotarget.24936
Angie B. Dull,
Deborah Wilsker,
Melinda Hollingshead,
Christina Mazcko,
Christina M. Annunziata,
Amy K. LeBlanc,
James H. Doroshow,
Robert J. Kinders,
and Ralph E. Parchment
|
| 17104-17116 |
89Zr-nimotuzumab for immunoPET imaging of epidermal growth factor receptor I
89Zr-nimotuzumab for immunoPET imaging of epidermal growth factor receptor I |
|
https://doi.org/10.18632/oncotarget.24965
Rufael Chekol,
Viswas Raja Solomon,
Elahe Alizadeh,
Wendy Bernhard,
Darrell Fisher,
Wayne Hill,
Kris Barreto,
John Francis DeCoteau,
Angel Casaco Parada,
Clarence Ronald Geyer,
and Humphrey Fonge
|
| 17117-17132 |
Age at menarche and risks of gestational diabetes mellitus: a meta-analysis of prospective studies
Age at menarche and risks of gestational diabetes mellitus: a meta-analysis of prospective studies |
|
https://doi.org/10.18632/oncotarget.23658
Ya Xiao,
Ruixue Chen,
Minghao Chen,
Anling Luo,
Dayi Chen,
Qiuer Liang,
Yunfei Cai,
Liguo Chen,
and Xiaoshan Zhao
|
| 17133-17140 |
Systematic review and meta-analysis of the prognostic significance of microRNAs in cervical cancer
Systematic review and meta-analysis of the prognostic significance of microRNAs in cervical cancer |
|
https://doi.org/10.18632/oncotarget.23839
Zhilan Chen,
Yingyan Han,
Chengwen Song,
Huafang Wei,
Ying Chen,
Kecheng Huang,
Shuang Li,
Ding Ma,
Shixuan Wang,
Jing Wang,
and Qiping Lu
|
| 17141-17148 |
Relationship between hospital volume and short-term outcomes: a nationwide population-based study including 75,280 rectal cancer surgical procedures
Relationship between hospital volume and short-term outcomes: a nationwide population-based study including 75,280 rectal cancer surgical procedures |
|
https://doi.org/10.18632/oncotarget.24699
Salvatore Pucciarelli,
Manuel Zorzi,
Nicola Gennaro,
Francesco Marchegiani,
Andrea Barina,
Massimo Rugge,
Matteo Zuin,
Alessandro Perin,
Isacco Maretto,
Francesca Bergamo,
Caterina Boso,
Emanuele Damiano Luca Urso,
Patrick Frambach,
and Maria Chiara Corti
|
| 17149-17159 |
Pharmacogenetics-based area-under-curve model can predict efficacy and adverse events from axitinib in individual patients with advanced renal cell carcinoma
Pharmacogenetics-based area-under-curve model can predict efficacy and adverse events from axitinib in individual patients with advanced renal cell carcinoma |
|
https://doi.org/10.18632/oncotarget.24715
Yoshiaki Yamamoto,
Ryouichi Tsunedomi,
Yusuke Fujita,
Toru Otori,
Mitsuyoshi Ohba,
Yoshihisa Kawai,
Hiroshi Hirata,
Hiroaki Matsumoto,
Jun Haginaka,
Shigeo Suzuki,
Rajvir Dahiya,
Yoshihiko Hamamoto,
Kenji Matsuyama,
Shoichi Hazama,
Hiroaki Nagano,
and Hideyasu Matsuyama
|
| 17160-17170 |
Head and neck squamous cell carcinoma and its correlation with human papillomavirus in people living with HIV: a systematic review
Head and neck squamous cell carcinoma and its correlation with human papillomavirus in people living with HIV: a systematic review |
|
https://doi.org/10.18632/oncotarget.24660
Manuela Ceccarelli,
Emmanuele Venanzi Rullo,
Alessio Facciolà,
Giordano Madeddu,
Bruno Cacopardo,
Rosaria Taibi,
Francesco D’Aleo,
Marilia Rita Pinzone,
Isa Picerno,
Michele di Rosa,
Giuseppa Visalli,
Fabrizio Condorelli,
Giuseppe Nunnari,
and Giovanni Francesco Pellicanò
|
| 17171-17180 |
Oxidative stress: role of physical exercise and antioxidant nutraceuticals in adulthood and aging
Oxidative stress: role of physical exercise and antioxidant nutraceuticals in adulthood and aging |
|
https://doi.org/10.18632/oncotarget.24729
Carolina Simioni,
Giorgio Zauli,
Alberto M. Martelli,
Marco Vitale,
Gianni Sacchetti,
Arianna Gonelli,
and Luca M. Neri
|
| 17181-17198 |
Physical training interventions for children and teenagers affected by acute lymphoblastic leukemia and related treatment impairments
Physical training interventions for children and teenagers affected by acute lymphoblastic leukemia and related treatment impairments |
|
https://doi.org/10.18632/oncotarget.24762
Carolina Simioni,
Giorgio Zauli,
Alberto M. Martelli,
Marco Vitale,
Simona Ultimo,
Daniela Milani,
and Luca M. Neri
|
| 17199-17209 |
Leptin signaling axis specifically associates with clinical prognosis and is multifunctional in regulating cancer progression
Leptin signaling axis specifically associates with clinical prognosis and is multifunctional in regulating cancer progression |
|
https://doi.org/10.18632/oncotarget.24966
Tsung-Chieh Lin,
Kuan-Wei Huang,
Chia-Wei Liu,
Yu-Chan Chang,
Wei-Ming Lin,
Tse-Yen Yang,
and Michael Hsiao
|
| 17210-17219 |
Influence of physical exercise on microRNAs in skeletal muscle regeneration, aging and diseases
Influence of physical exercise on microRNAs in skeletal muscle regeneration, aging and diseases |
|
https://doi.org/10.18632/oncotarget.24991
Simona Ultimo,
Giorgio Zauli,
Alberto M. Martelli,
Marco Vitale,
James A. McCubrey,
Silvano Capitani,
and Luca M. Neri
|
| 17220-17237 |
Cardiovascular disease-related miRNAs expression: potential role as biomarkers and effects of training exercise
Cardiovascular disease-related miRNAs expression: potential role as biomarkers and effects of training exercise |
|
https://doi.org/10.18632/oncotarget.24428
Simona Ultimo,
Giorgio Zauli,
Alberto M. Martelli,
Marco Vitale,
James A. McCubrey,
Silvano Capitani,
and Luca M. Neri
|
| 17238-17254 |
Correction: The dual PI3K/mTOR inhibitor dactolisib elicits anti-tumor activity in vitro and in vivo
Correction: The dual PI3K/mTOR inhibitor dactolisib elicits anti-tumor activity in vitro and in vivo |
|
https://doi.org/10.18632/oncotarget.25063
Fei Shi,
Jinying Zhang,
Hongyu Liu,
Liangliang Wu,
Hongyu Jiang,
Qiyan Wu,
Tianyi Liu,
Meiqing Lou,
and Hao Wu
|
| 17255-17255 |
Correction: Evaluation of tenascin-C by tenatumomab in T-cell non-Hodgkin lymphomas identifies a new target for radioimmunotherapy
Correction: Evaluation of tenascin-C by tenatumomab in T-cell non-Hodgkin lymphomas identifies a new target for radioimmunotherapy |
|
https://doi.org/10.18632/oncotarget.25064
Giuseppe Gritti,
Andrea Gianatti,
Fiorella Petronzelli,
Rita De Santis,
Chiara Pavoni,
Riccardo Lorenzo Rossi,
Laura Cattaneo,
Luigi Giusto Spagnoli,
Silvia Ferrari,
Andrea Rossi,
Anna Maria Barbui,
and Alessandro Rambaldi
|
| 17256-17256 |
